Form 4 for NVCR NovoCure Ltd
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001194459-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-03 | NVCR | DOYLE WILLIAM F | Executive COB, Dir | A - Grant | $0.00 | +400.3K | 200.0K | New | $0 |
| DM | 2026-03-05 | 2026-03-03 | NVCR | DOYLE WILLIAM F | Executive COB, Dir | S - Sale | $12.98 | -71.9K | 349.7K | -17% | -$933.1K |
| DM | 2026-03-05 | 2026-03-03 | NVCR | DOYLE WILLIAM F | Executive COB, Dir | A - Grant | $0.00 | +288.5K | 258.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-03 | A | A | 200,284 | $0.00 | 400,284 | D | — | — | (F2) Represents vesting of performance-based restricted stock units. |
| 2 | Common | Ordinary Shares | 2026-03-03 | S | D | 21,330 | $13.43 | 328,397 | D | — | — | (F3) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance-Based Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. (F5) This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.52 USD; the price reported above reflects the weighted average sale price. |
| 3 | Common | Ordinary Shares | 2026-03-03 | S | D | 50,557 | $12.79 | 349,727 | D | — | — | (F3) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance-Based Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. (F4) This transaction was executed in multiple trades at prices ranging from $12.299 USD to $13.277 USD; the price reported above reflects the weighted average sale price. |
| 4 | Common | Ordinary Shares | 2026-03-03 | A | A | 200,000 | $0.00 | 200,000 | D | — | — | (F1) Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-03-03 | A | A | 30,072 | $0.00 | 288,517 | D | $13.30 · — to 2036-03-03 | 30,072 Ordinary Shares | (F6) Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-03-03 | A | A | 258,445 | $0.00 | 258,445 | D | $13.30 · — to 2036-03-03 | 258,445 Ordinary Shares | (F6) Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date. |